<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Community:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/477</link>
    <description />
    <pubDate>Sun, 22 Nov 2026 20:19:08 GMT</pubDate>
    <dc:date>2026-11-22T20:19:08Z</dc:date>
    <item>
      <title>The pharmacist : a transition ambassador for teenage patients with type 1 diabetes mellitus</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/150954</link>
      <description>Title: The pharmacist : a transition ambassador for teenage patients with type 1 diabetes mellitus
Abstract: Type 1 diabetes mellitus is a chronic autoimmune disease characterised by absolute &#xD;
insulin deficiency, requiring lifelong insulin therapy and continuous self-management. &#xD;
Transitioning from paediatric, family-centred care to adult, patient-centred care is a &#xD;
vulnerable period for adolescents and caregivers, highlighting the need for structured &#xD;
transition support. This study aimed to develop a pharmacist-led transition of care &#xD;
model by identifying predictors of poor glycaemic control, exploring perceptions of &#xD;
pharmacists’ roles among patients, caregivers, and healthcare professionals, developing &#xD;
and validating a transition tool kit, and identifying implementation gaps in community &#xD;
settings. The study was conducted in four phases. Phase 1 involved developing and &#xD;
validating assessment tools, including the Self-Management Assessment Questionnaire, &#xD;
Parents’ Concerns Questionnaire, and Role of the Pharmacist Questionnaire, with data &#xD;
collected via targeted social media groups during the COVID-19 pandemic. Findings &#xD;
informed the development of the pharmacist-led transition program, On Your Marks, &#xD;
Get Set, Transition, comprising seven sections focusing on stakeholder education, &#xD;
patient and caregiver preparation, clinical documentation, staged readiness &#xD;
assessments, and caregiver support. The tool kit is designed for integration into the &#xD;
national healthcare system through Pharmacy of Your Choice (POYC) service, where &#xD;
pharmacists act as transition coordinators, providing structured education, monitoring &#xD;
readiness, supporting self-management, and facilitating communication and handover &#xD;
to adult services. Feedback from Maltese community pharmacists highlighted limited &#xD;
knowledge of transition care, but supported gradual transition, and identified the need &#xD;
for dedicated consultations. The tool kit demonstrates potential to improve continuity &#xD;
of care, patient engagement, and transition outcomes, although implementation &#xD;
requires additional training, time, and resources.
Description: Ph.D.(Melit.)</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/150954</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Professional identity formation in pharmacy in the era of artificial intelligence</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/150940</link>
      <description>Title: Professional identity formation in pharmacy in the era of artificial intelligence
Authors: Elnaem, Mohamed Hassan; Birnie, Christine R.; Cheung, Nicole C.; Okuyan, Betul; Sammut Bartolo, Nicolette; Sandhu, Anisha Kaur; Schellhase, Ellen M.; Sertić, Miranda; Tangiisuran, Balamurugan; Wirth, Francesca; Ryan, Melody
Abstract: Introduction&#xD;
Professional identity formation (PIF), the developmental process through which practitioners come to think, act, and feel as pharmacists, has historically been shaped by experiential learning, participation in communities of practice, and socialization in professional culture. The rapid integration of artificial intelligence (AI) in educational, clinical and operational pharmacy settings represents a system-level disruption to these established pathways. However, there is limited guidance on how to navigate this transition intentionally and constructively. This position paper aims to: (1) evaluate how generative AI technologies are reshaping the core pharmacy competencies; (2) examine the pedagogical, operational and ethical challenges AI poses to traditional PIF pathways; (3) identify emerging pharmacist professional identities in the AI era; and (4) propose actionable, globally relevant recommendations for pharmacy educators, regulators, health systems, and practitioners.; Methods&#xD;
This position paper was developed through an author-led, literature-informed synthesis conducted by the Research and Scholarship Working Group of the Internaitonal Pharmaceutical Federation Academic Pharmacy Section. Literature was identified through targeted searches related to PIF, pharmacy education and practice, and AI in healthcare with purposive selection of peer-reviewed and grey literature and professional framework documents. Four key thematic domains are discussed: conceptual foundations of PIF, evolving AI landscape in healthcare and pharmacy, challenges to traditional PIF pathways, and opportunities to develop an enhanced professional identity.; Results&#xD;
AI is more likely to augment rather than replace pharmacist roles, redistributing cognitive effort toward higher-order clinical, consultative, supervisory, and governance functions. However, the risks of deskilling, automation bias and ethical dissonance, particularly when AI outputs conflict with professional judgements or reflect dataset biases, present substantive threats to identity coherence. Four professional roles emerged: AI-augmented clinician, translator and integrator of AI outputs, ethical guardian and data steward, and co-designer and validator of AI systems in pharmacy. Global inequities in AI access, implementation and governance, particularly in low- and middle-income settings, further compound these challenges.&#xD;
Pharmacy curricula should embed AI literacy, data ethics, and critical appraisal as core competencies, supported by simulation-based pedagogy and faculty development. Professional bodies should update competency frameworks to integrate emerging AI-related professional identities. At the same time, health systems should redesign workflows that cultivate continuous digital upskilling alongside ethical vigilance. A coordinated global response is required to ensure that AI enhances the patient-centered, ethically grounded identity that defines the pharmacy profession.; Conclusion&#xD;
The profession must not respond to AI defensively but instead deepen the human-centered values that define pharmacy practice that algorithms cannot replicate, namely empathy, ethical stewardship, and relational expertise. This position paper provides a global framework to support those elements in PIF.</description>
      <pubDate>Fri, 01 Jan 2027 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/150940</guid>
      <dc:date>2027-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A risk-based approach towards drug-related problems in community pharmacy practice</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/150288</link>
      <description>Title: A risk-based approach towards drug-related problems in community pharmacy practice
Abstract: Drug-related problems (DRPs), defined by the Pharmaceutical Care Network Europe as “events or circumstances involving drug therapy that actually or potentially interfere with desired health outcomes”. They can arise from prescribing and dispensing errors, inappropriate medication use, and polypharmacy. As highly accessible healthcare providers, community pharmacists are well positioned to identify, assess, and prevent DRPs, improving patient pharmacotherapy.; Aims: ▫ To identify and quantify drug-related problems in community pharmacies; ▫ To put forward strategies to minimise drug-related problems in community pharmacies</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/150288</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Health and safety risks in community and hospital pharmacy</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/150287</link>
      <description>Title: Health and safety risks in community and hospital pharmacy
Abstract: Health and safety risks in pharmacies are a growing concern in prominent pharmaceutical settings such as community and hospital. By mitigating the risks in these settings, these environments may be made safer for pharmacists, patients, and staff alike.; Aims: To identify and quantify health and safety risks in&#xD;
community and hospital pharmacy settings, and&#xD;
To put forward risk mitigation strategies to minimise the&#xD;
occurrence of these risks and create safer environments.</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/150287</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

